Showing results (131-140 of 192) with videos related to

Sort By:
Pageof 20
The Oncologist|November 9, 2025
Phase Ib study of berzosertib, carboplatin, gemcitabine, and pembrolizumab in patients with squamous nonsmall lung cancer (ETCTN 10313)Liza C Villaruz, Benjamin Schluger, Hong Wang, et al.
Cancer Chemotherapy and Pharmacology|January 9, 2015
A phase I, pharmacokinetic, and pharmacodynamic evaluation of the DNA methyltransferase inhibitor 5-fluoro-2'-deoxycytidine, administered with tetrahydrouridineEdward M Newman, Robert J Morgan, Shivaani Kummar, et al.
Cancer Chemotherapy and Pharmacology|November 28, 2025
Phase Ib study of enzalutamide with venetoclax in patients with metastatic castration-resistant prostate cancerStuthi Perimbeti, Anmbreen Jamroze, Dharmesh Gopalakrishnan, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|November 9, 2020
Improved chemosensitivity following mucolytic therapy in patient-derived models of mucinous appendix cancerAshok K Dilly, Brendon D Honick, Robin Frederick, et al.
Plos One|August 7, 2015
Combined PDGFR and HDAC Inhibition Overcomes PTEN Disruption in ChordomaDae-Hee Lee, Ying Zhang, Amin B Kassam, et al.
Leukemia & Lymphoma|October 17, 2019
Phase 1 study of the Aurora kinase A inhibitor alisertib (MLN8237) combined with the histone deacetylase inhibitor vorinostat in lymphoid malignanciesTanya Siddiqi, Paul Frankel, Jan H Beumer, et al.
Cancer Research|February 19, 2009
Sulforaphane inhibits prostate carcinogenesis and pulmonary metastasis in TRAMP mice in association with increased cytotoxicity of natural killer cellsShivendra V Singh, Renaud Warin, Dong Xiao, et al.
Cancer Chemotherapy and Pharmacology|May 6, 2010
Plasma pharmacokinetics and oral bioavailability of the 3,4,5,6-tetrahydrouridine (THU) prodrug, triacetyl-THU (taTHU), in miceJan H Beumer, Julie L Eiseman, Judith A Gilbert, et al.
Cancer Chemotherapy and Pharmacology|October 20, 2021
A phase I study of veliparib with cyclophosphamide and veliparib combined with doxorubicin and cyclophosphamide in advanced malignanciesAntoinette R Tan, Nancy Chan, Brian F Kiesel, et al.
Cancer Chemotherapy and Pharmacology|August 29, 2014
Effect of age on the pharmacokinetics of busulfan in patients undergoing hematopoietic cell transplantation; an alliance study (CALGB 10503, 19808, and 100103)Jan H Beumer, Kouros Owzar, Lionel D Lewis, et al.
Pageof 20